China Universal Asset Management Company’s Janux Therapeutics JANX Stock Holding History

China Universal Asset Management Company’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$149K	Sell	9,706 -1,089	-10%	-$15.8K	0.01%	379
2026 Q1	$150K	Buy	10,795 +994	+10%	+$13.6K	0.01%	374
2025 Q4	$135K	Sell	9,801 -733	-7%	-$17.2K	0.01%	386
2025 Q3	$257K	Sell	10,534 -1,351	-11%	-$32.9K	0.02%	312
2025 Q2	$275K	Buy	11,885 +30	+0.3%	+$790	0.03%	286
2025 Q1	$320K	Buy	11,855 +727	+7%	+$27.4K	0.03%	281
2024 Q4	$596K	Buy	11,128 +1,095	+11%	+$57.9K	0.06%	231
2024 Q3	$456K	Buy	10,033 +3,943	+65%	+$172K	0.05%	233
2024 Q2	$255K	Sell	6,090 -3,653	-37%	-$172K	0.04%	210
2024 Q1	$367K	Buy	9,743 +4,400	+82%	+$95.8K	0.05%	212
2023 Q4	$57.3K	Buy	+5,343	New	+$46.2K	0.01%	359
2022 Q4	–	Sell	-390	Closed	-$5K	–	423
2022 Q3	$5K	Buy	+390	New	+$5.21K	﹤0.01%	273

Other funds holding JANX

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

RBI

Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

China Universal Asset Management Company's JANX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Janux Therapeutics (JANX) stake by 10% in Q2 2026, selling an estimated $15.8K and leaving 9,706 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #379.

China Universal Asset Management Company first reported a position in JANX in Q3 2022 and has held it in 12 quarters since. The position peaked at $596K in Q4 2024. 48 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

China Universal Asset Management Company held 9,706 shares of Janux Therapeutics worth $149K as of Q2 2026.
China Universal Asset Management Company sold 1,089 Janux Therapeutics shares in Q2 2026, an estimated $15.8K.
Janux Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #379 holding.
China Universal Asset Management Company first reported a position in Janux Therapeutics in Q3 2022 and has held it in 12 quarters since.
China Universal Asset Management Company's Janux Therapeutics position peaked at $596K in Q4 2024.
48 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.